The Pediatric Leukemia and Lymphoma Steering Committee (PLLSC) addresses the design, prioritization, and evaluation of concepts for large clinical trials in pediatric hematologic cancers. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The PLLSC's membership comprises Children's Oncology Group (COG) representatives, community oncologists, biostatisticians, patient advocates, subject matter experts, and NCI staff.
Chair
Stephen Patrick Hunger, M.D.
Children's Hospital of Philadelphia
Vice Chair
Tanja A. Gruber, M.D., Ph.D.
Stanford University
Members
Anjali Advani, M.D.
Cleveland Clinic
Jameisha Brown, M.S.
Patient Advocate
Michael James Burke, M.D.
Children's Wisconsin
Jessica M. Foley, M.D.
Cancer Research Consortium of West Michigan
Boris Freidlin, Ph.D.
National Cancer Institute
Rebecca Alice Gardner, M.D.
St. Jude Children's Research Hospital
Robert J. Hayashi, M.D.
Washington University St. Louis
Eric Jeffrey Lowe, M.D.
Children's Hospital of The King's Daughters
Selina M. Luger, M.D.
University of Pennsylvania
Megan Othus, Ph.D.
Fred Hutchinson Cancer Research Center
Pinki Kumari Prasad, M.D., M.P.H.
Louisiana State University Health Sciences Center
Elizabeth Ann Raetz, M.D.
NYU Grossman School of Medicine
Charles J. Schmaderer, M.B.A.
Patient Advocate
Nita Seibel, M.D.
National Cancer Institute
Lewis B. Silverman, M.D.
Columbia University Irving Medical Center
Malcolm Smith, M.D., Ph.D.
National Cancer Institute
Matt Robert Sydes, M.Sc.
NHS England
Naomi Winick, M.D.
University of Texas Southwestern Medical Center
NCI CCCT Program Director
Elena Schwartz, Ph.D., M.S.
elena.schwartz@nih.gov